13/04/2026
🌍 What’s New(s) Monday | Global Cannabis Update
13 April 2026
Across global cannabis markets, the conversation is beginning to shift from access to affordability.
As more countries move toward regulated medical cannabis systems, governments and healthcare providers are increasingly debating how treatment should be paid for. Markets such as France are moving closer to national medical cannabis frameworks, with growing discussion around pricing and reimbursement.
This marks an important next phase for the industry. The question is no longer only whether patients can legally access medical cannabis — it is whether they will be able to afford it.
For those of us watching the industry from South Africa, this is an important global trend to follow. As international markets evolve, questions around affordability, reimbursement, and access may eventually become increasingly relevant locally too.
💬 Industry question:
What do you think will have the biggest impact on patient access in future — insurance coverage, lower costs, or stronger medical evidence?
👇 Share your perspective below.
